Resectable Esophageal Squamous Cell Carcinoma Clinical Trials in Shanghai, Shanghai Municipality

Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.